Healthcare Realty Trust Incorporated (HR)
(Delayed Data from NYSE)
$14.38 USD
+0.15 (1.05%)
Updated Apr 23, 2024 03:59 PM ET
After-Market: $14.37 -0.01 (-0.07%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth A Momentum B VGM
Healthcare Realty Trust (HR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$16.89 | $20.00 | $15.00 | 18.69% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for Healthcare Realty Trust comes to $16.89. The forecasts range from a low of $15.00 to a high of $20.00. The average price target represents an increase of 18.69% from the last closing price of $14.23.
Analyst Price Targets (9 )
Broker Rating
Healthcare Realty Trust currently has an average brokerage recommendation (ABR) of 2.45 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms. The current ABR compares to an ABR of 2.45 a month ago based on 11 recommendations.
Of the 11 recommendations deriving the current ABR, three are Strong Buy, representing 27.27% of all recommendations. A month ago, Strong Buy represented 27.27%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 8 | 8 | 8 | 10 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.45 | 2.45 | 2.45 | 2.54 | 2.23 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
2/20/2024 | Wedbush Securities | Richard Anderson | Strong Buy | Hold |
1/2/2024 | BTIG | Michael Gorman | Strong Buy | Strong Buy |
10/10/2023 | Scotiabank | Nicholas Yulico | Hold | Hold |
10/7/2023 | KeyBanc Capital Markets | Austin Wurschmidt | Hold | Hold |
10/6/2023 | BMO Capital Markets | Juan Sanabria | Not Available | Hold |
10/2/2023 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.45 |
ABR (Last week) | 2.45 |
# of Recs in ABR | 11 |
Average Target Price | $16.89 |
LT Growth Rate | NA |
Industry | REIT and Equity Trust - Other |
Industry Rank by ABR | 91 of 252 |
Current Quarter EPS Est: | 0.38 |